RBRK.NYSERubrik, INC

Form 4: Rubrik Director Asheem Chandna Receives Significant RSU Grant

Sentiment:

Insider Trading Report


Rubrik, Inc. Director Asheem Chandna reported the acquisition of 2,702 Class A Common Stock shares through a Restricted Stock Unit (RSU) grant, with vesting scheduled through June 2026.

Summary

  • Asheem Chandna, a Director at Rubrik, Inc. (RBRK), reported a change in beneficial ownership via an SEC Form 4 filing.
  • The filing details the acquisition of 2,702 shares of Class A Common Stock on June 25, 2025, through a Restricted Stock Unit (RSU) grant.
  • These RSUs were granted at a price of $0, which is typical for such compensation.
  • The RSUs will vest in four equal quarterly installments, beginning on September 15, 2025, and continuing on December 15, 2025, March 15, 2026, and June 15, 2026, contingent upon Mr. Chandna's continuous service to the Issuer.
  • Following this transaction, Mr. Chandna directly beneficially owns 848,889 shares of Class A Common Stock.
  • Additionally, Mr. Chandna indirectly beneficially owns 6,972 shares through the Chandna Children's Trust and 34,863 shares through The Revocable Trust of Asheem Chandna and Aarti Chandna.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. It's a routine compensation event for a director, indicating continued alignment with the company, but does not convey significant new operational or financial performance information.

Positives

  • The RSU grant aligns the director's interests with long-term shareholder value through a vesting schedule tied to continued service.
  • The grant represents ongoing compensation and commitment from a key director.

Risks

  • The vesting of RSUs is subject to the reporting person's continuous service with the Issuer, meaning the shares could be forfeited if service ceases before vesting dates.

Future Outlook

The RSU grant includes a future vesting schedule, with one quarter of the units vesting on September 15, 2025, December 15, 2025, March 15, 2026, and June 15, 2026, subject to the director's continuous service.

Industry Context

This Form 4 filing is a routine disclosure of insider equity compensation, common across publicly traded companies in the technology sector and beyond, reflecting standard practices for aligning executive and director incentives with company performance.

Related Party Transactions

  • Indirect beneficial ownership through the Chandna Children's Trust and The Revocable Trust of Asheem Chandna and Aarti Chandna, which are common arrangements for insider holdings.

Stakeholder Impact

  • Shareholders: Minor potential dilution from the RSU grant, but it aligns the director's long-term interests with shareholder value.
  • Employees: The grant is specific to a director and does not directly impact the broader employee base, though it reflects standard compensation practices for leadership.

Next Steps

  • Vesting of RSUs on September 15, 2025, December 15, 2025, March 15, 2026, and June 15, 2026, contingent on continuous service.

Key Dates

DateDescription
04/13/1998Date of The Revocable Trust of Asheem Chandna and Aarti Chandna, UDT
12/23/2012Date of Chandna Children's Trust
06/25/2025Date of RSU grant transaction
06/27/2025Date of SEC Form 4 filing signature
09/15/2025First vesting date for RSUs (one quarter)
12/15/2025Second vesting date for RSUs (one quarter)
03/15/2026Third vesting date for RSUs (one quarter)
06/15/2026Fourth and final vesting date for RSUs (one quarter)

Keywords

Rubrik, RBRK, SEC Form 4, Restricted Stock Units, RSU grant, beneficial ownership, insider transaction, Asheem Chandna, director compensation, equity compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.